Skip to main content
. Author manuscript; available in PMC: 2019 Jul 9.
Published in final edited form as: Chem Rev. 2018 Oct 18;118(22):11194–11258. doi: 10.1021/acs.chemrev.8b00369

Figure 75.

Figure 75

DADMe-ImmH (called Ulodestin in this trial) lowers serum urate in combination with allopurinol in gout patients. Percent of patients achieving serum urate less than 6.0 mg/dL for Ulodesine and Allopurinol dosing groups.. Reproduced with permission from ref 411. Copyright 2014 Elsevier.